A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: trivial (7), unimportant (1), insignificant (12), minor (223), subsidiary (31), secondary (109)

Patient-initiated follow-up (PIFU) for CLL, SLL, LMZL and HCL - patient information

Description
This booklet contains a summary of patient-initiated follow-up (PIFU) for chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), leukaemic
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Patient-initiated-follow-up-PIFU-for-CLL-SLL-LMZL-and-HCL-3322-PIL.pdf

Finance and Performance Reports 2022-23 Month 2 May 2022

Description
Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Issue to be addre
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Finance-and-Performance-Reports-2022-23-Month-2-May-2022.pdf

Finance and Performance Reports 2020-21 Month 4 July 2020

Description
2020/21 Finance Report - Month 4 Report to: Board of Directors and Finance & Investment Committee August 2020 Title: Finance Report for Per
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/finance-and-performance-reports-2020-21-month-4-july-2020-1.pdf

FoM Research Conference programme - final

Description
Faculty of Medicine Research Conference PROGRAMME Tuesday 14th June 2022 Microsoft Teams TIME EVENT SPEAKER 09.15-09.20 MICROSOFT TEAMS CONFERENC
Url
/Media/Southampton-Clinical-Research/Downloads/FoM-Research-Conference-programme-final.pdf

Rituximab SC (8 weekly) Ver 1

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (8 weekly) Regimen Lymphoma – Rituximab SC (8 weekly) Indication Maintenance single agent therapy in previously untreated f
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-8-weekly-Ver-1.pdf

Rituximab SC (12 weekly) Ver1

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (12 weekly) Regimen Lymphoma – Rituximab SC (12 weekly) Indication Maintenance single agent therapy in relapsed / refractory
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-12-weekly-Ver1.pdf

Papers Trust Board - 25 July 2024

Description
Agenda Trust Board – Open Session Date 25/07/2024 Time 9:00 - 13:00 Location Anaesthetic Seminar Room (CE95/99), E
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-25-July-2024.pdf

Papers Trust Board - 13 January 2026

Description
Date Time Location Chair Apologies Agenda Trust Board – Open Session 13/01/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-13-January-2026.pdf

Papers Trust Board - 11 November 2025

Description
Date Time Location Chair Agenda Trust Board – Open Session 11/11/2025 9:00 - 13:00 Conference Room, Heartbeat Education Centre
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-11-November-2025.pdf

Finance and Performance Reports 2021-22 month 4 July 2021

Description
Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Issue to be addressed: Finance Repo
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2021-Trust-document/Finance-and-performance-reports/Finance-and-Performance-Reports-2021-22-Month-4-July-2021.pdf
1 to 10 of 12
Previous 1 2 Next